Texas and Florida Sue FDA Over Abortion Pill Access
Here’s a summary of the provided text, focusing on the key points:
* New Lawsuit: Texas, Florida, and Louisiana have filed a lawsuit challenging the FDA’s approval of both the original mifepristone and its generic version (Evita solutions). They also challenge regulations expanding access to the drug.
* Safety of Mifepristone: Over 100 studies confirm mifepristone is a safe and effective medication for ending a pregnancy. It’s used in over 60% of US abortions,typically in the first 10 weeks,in combination with misoprostol.
* FDA Approval & Political Context: The FDA approved the generic version of mifepristone under the Trump management, despite conservative opposition. The lawsuit claims the FDA acted “arbitrarily and capriciously.”
* ACLU Response: The ACLU argues the lawsuit isn’t about safety, but about restricting abortion access. They characterize it as an attempt to ban a widely used and safe medication.
* Similar Case: This lawsuit mirrors claims made in a separate case brought by Missouri, Kansas, and Idaho.Texas, Florida, and louisiana previously attempted to join that case.
In essence, the article details a new legal challenge to mifepristone’s availability, framed within the ongoing political battle over abortion access in the United States.